Home › Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho
 

Keywords :   


Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho

2016-04-10 23:14:22| Biotech - Topix.net

's stock had its "buy" rating reaffirmed by investment analysts at Mizuho in a research report issued on Sunday, Marketbeat.com reports. They presently have a $130.00 target price on the biopharmaceutical company's stock.

Tags: rating sciences gilead mizuho

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05Comcast releases research on how viewers discover new TV content
10.05Samba TV uses GenAI to provide actionable context for video ads
10.05Roku unveils screensaver ad integrations, ad partnerships and fresh content
10.05Samsung TV Plus partners with MLB, PGA Tour, F1 and ONE Championship
10.05UK emerged from recession at start of year
10.05UK economy out of recession, official figures show
10.05Rat remains found in bread sparks Japan recall and refunds
10.05Argentines strike against spending cuts
More »